Adenosine deaminases acting on RNA (ADARs) catalyze hyperediting of long double-stranded RNAs (dsRNAs), whereby up to 50% of adenosines are converted to inosine (I). Although hyperedited dsRNAs (IU-dsRNAs) have been implicated in various cellular functions, we now provide evidence for another role. We show that IU-dsRNA suppresses the induction of interferon-stimulated genes (ISGs) and apoptosis by poly(IC). Moreover, we show that IU-dsRNA inhibits the activation of interferon regulatory factor 3 (IRF3), which is essential for the induction of ISGs and apoptosis. Finally, we speculate that the inhibition of IRF3 results from specific binding of IU-dsRNA to MDA-5 or RIG-I, both of which are cytosolic sensors for poly(IC). Although our data are consistent with a previous study in which ADAR1 deletion resulted in increased expression of ISGs and apoptosis, we show that IU-dsRNA per se suppresses ISGs and apoptosis. We therefore propose that any IU-dsRNA generated by ADAR1 can inhibit both pathways.
a r t i c l e s ADARs catalyze the deamination of adenosine (A) to inosine (I) in dsRNA 1, 2 . ADARs have been characterized throughout the metazoa, although the number of ADAR genes expressed in each organism differs. Three ADARs have been described in mammals (ADAR1-3), although only ADAR1 and ADAR2 seem to be catalytically active. The importance of ADARs in post-transcriptional gene regulation has been shown by analysis of ADAR-null mutants 1, 2 .
Although A-to-I editing can occur selectively in mRNA, hyperediting of long dsRNA can result in up to 50% of A residues being changed to I. As I is decoded as guanosine by ribosomes, A-to-I editing can result in codon changes. Localized changes in RNA structure are also likely to occur in IU-dsRNAs, as IU pairs are weaker than conventional base pairs 3 . In mammals, most editing occurs in noncoding regions of RNA, including repetitive elements such as inverted Alus [4] [5] [6] [7] . However, although countless RNAs might be extensively edited, the possible functions of IU-dsRNAs in cells are not fully understood. Various studies have suggested that IU-dsRNAs undergo diverse fates [8] [9] [10] [11] [12] [13] .
Two main isoforms of ADAR1 have been described in mammalian cells. A constitutively expressed truncated ADAR1 protein (p110) localizes to the nucleus, whereas full-length interferon-inducible ADAR1 (p150) 14 shuttles between the nucleus and the cytoplasm 15 . Mice lacking ADAR1 die at around embryonic day 11.5 (E11.5) owing to defective hematopoiesis and widespread apoptosis 16, 17 . This can be explained by the finding that ADAR1 is indispensable for the maintenance of hematopoietic stem cells in fetal liver and adult bone marrow 17 . In addition, ADAR1 suppresses the activation of ISGs, thereby protecting against premature apoptosis 17 . Several ideas have been put forward to explain how ADAR1 might regulate interferon signaling. Editing of crucial, unidentified transcripts by ADAR1 might be important.
A complex needed for interferon regulation might be disrupted in the absence of ADAR1. Alternatively, the lack of editing in ADAR1deficient cells might give rise to immunoreactive dsRNA 17 .
Here we present experimental data that support an alternative explanation for how ADAR1 regulates interferon signaling. We provide evidence that IU-dsRNA itself is sufficient to suppress the activation of ISGs. When we transfected human cells (HeLa) with short dsRNAs containing multiple IU pairs, the induction of ISGs by long dsRNA was suppressed. Microarrays confirmed that suppression of gene expression by IU-dsRNA was largely restricted to genes involved in immunity and defense. We also show that IU-dsRNA inhibited apoptosis induced by long dsRNA. Both suppressive effects mediated by IU-dsRNA could be accounted for by our observation that IU-dsRNA inhibited activation of IRF3, a key component in the pathway by which long dsRNA induces ISG activation and apoptosis 18 . Moreover, our data suggest that IU-dsRNA acts at an early step in the pathway by specifically inhibiting melanoma differentiation-associated protein 5 (MDA-5) or retinoic acid-inducible gene I (RIG-I), the cytosolic sensors for dsRNA 19 . These observations lead us to propose that any IU-dsRNA generated by editing can directly inhibit interferon induction and apoptosis.
RESULTS

IU-dsRNA does not induce an interferon response
In HeLa cells, IU-dsRNA downregulates both endogenous and reporter gene expression 13 . In addition, IU-dsRNA binds a complex that comprises stress-granule components 13 . Stress granules function during cellular stress to allow proteins that are needed for survival to be selectively synthesized 20 . In considering how IU-dsRNA downregulates 1 0 4 4 VOLUME 17 NUMBER 9 SEPTEMBER 2010 nature structural & molecular biology a r t i c l e s gene expression, we speculated that IU-dsRNA might elicit an interferon response. Although interferon is typically induced by long dsRNAs, it is possible that IU-dsRNA in cells signifies stress and induces interferon. Induction of interferon would activate a signaling cascade that would culminate in the transcription of hundreds of ISGs that function in cellular stress response pathways 21 . We therefore tested whether IU-dsRNA in HeLa cells triggered an interferon response.
We transfected HeLa cells with control or IU-dsRNA (C-IU) duplexes ( Table 1) , with or without Firefly luciferase (Fluc) mRNA. The inclusion of Fluc mRNA allowed us to monitor the effect of IU-dsRNA on reporter gene expression (data not shown). Control and C-IU were identical except for the four central base pairs; the control dsRNA consisted of Watson-Crick base pairs, whereas C-IU dsRNA contained IU pairs. We harvested cells 6 or 12 h after transfection, and used reverse transcription (RT) and quantitative PCR (qPCR) to quantify the expression of various ISGs ( Fig. 1a and Supplementary Table 1 ). The ISGs tested corresponded to a subset of those upregulated by interferon treatment or ADAR1 deficiency 17 . We also analyzed the expression of ACTB (β-actin). We calculated the fold change in mRNA levels at 12 h relative to those at 6 h with control dsRNA and normalized them to GAPDH. Six hours after transfection, we saw no induction of ISGs (data not shown). Unless stated otherwise, we calculated fold change in the same way for subsequent experiments. For all genes tested, expression did not change when we transfected cells with control or C-IU dsRNA in the absence of Fluc mRNA ( Fig. 1a) . By contrast, the expression of all ISGs tested was substantially higher in the presence of Fluc mRNA and control dsRNA (Fig. 1a) . The increase was significantly smaller with C-IU dsRNA and Fluc mRNA. The expression of ACTB remained constant. These data suggested that Fluc mRNA caused induction of the ISGs and that IU-dsRNA suppressed the response.
To verify that the ISGs were upregulated by Fluc mRNA, we transfected HeLa cells with Fluc mRNA alone. We analyzed the fold change in gene expression after 12 h using reverse transcription quantitative PCR (RT-qPCR), relative to that seen without Fluc mRNA ( Fig. 1b) . Increasing concentrations of Fluc mRNA produced a corresponding increase in ISG expression. The expression of ACTB was unchanged. These data confirm that Fluc mRNA in HeLa cells induced ISGs. It was possible that this was due to contamination of the Fluc mRNA with a small amount of dsRNA, as reported previously 22 . Alternatively, any uncapped mRNA present in the in vitro-transcribed preparation of 'capped' Fluc mRNA could activate an interferon response by interacting with RIG-I, which responds to 5′-triphosphate single-stranded (ss)RNA 19 . Analysis of the Fluc mRNA 5′ end confirms that a proportion of the RNA was uncapped, consistent with inefficient in vitro capping 23 (Supplementary Fig. 1a ; see Supplementary Methods). Moreover, RT-qPCR confirms that RIG-I expression was induced by either capped or uncapped Fluc mRNA (Supplementary Fig. 1b,c) . Notably, these data also show that C-IU dsRNA suppressed the induction of ISGs when we used uncapped RNA to trigger the immune response.
These experiments show that IU-dsRNA in HeLa cells did not induce an interferon response. On the contrary, they unexpectedly show that IU-dsRNA suppressed the induction of ISGs.
Different IU-dsRNAs suppressed the interferon response
To ensure that the observed effect was unrelated to the sequence of the short dsRNAs, we used two additional pairs of duplexes, GP and IIUI, and miR-142 (142) and miR-142-IU (142-IU; Table 1 ) to transfect HeLa cells along with Fluc mRNA. For each pair, the dsRNAs were identical except for the presence or absence of IU pairs. Again, we analyzed the expression of ACTB and various ISGs after 12 h using RT-qPCR ( Fig. 1c) .
The expression of all ISGs tested was considerably higher with control dsRNAs (C, GP, 142) but not with the corresponding IU-dsRNA (C-IU, IIUI, 142-IU). The expression of ACTB was constant. These data support the idea that IU-dsRNA suppressed the induction of ISGs and show that suppression occurred in a sequence-independent manner.
IU-dsRNA suppressed ISG induction by poly(IC)
IU-dsRNA inhibited the induction of ISGs by Fluc mRNA. We next tested whether IU-dsRNA similarly suppressed the induction of ISGs in response to poly(IC), which effectively mimics long dsRNA.
We initially analyzed the induction of ISGs in HeLa cells transfected with increasing amounts of poly(IC) ( Fig. 2a) . We used RT-qPCR to quantify the expression of various ISGs after 12 h, relative to that without poly(IC). As the concentration of poly(IC) increased, the expression of ISG showed a corresponding increase ( Fig. 2a) . The expression of ACTB was constant. These data confirm that transfection of HeLa cells with poly(IC) induced ISG expression 24 .
We next tested the effect of C-IU dsRNA on the induction of ISGs by poly(IC). We transfected HeLa cells with either control or C-IU dsRNA, with or without poly(IC). We quantified the expression of various ISGs and of several control genes not induced by interferon after 12 h using RT-qPCR. In the absence of poly(IC), the expression of all genes was constant with either control or C-IU dsRNA (data not shown). However, when we co-transfected HeLa cells with poly(IC) and control dsRNA, the expression of all ISGs tested was higher ( Fig. 2b) . By contrast, the induction of ISGs was suppressed by C-IU dsRNA (Fig. 2b) . The expression of control genes was constant ( Fig. 2b) . These data therefore reinforce the previous observations in that they show that IU-dsRNA suppressed the induction of ISGs by poly(IC). Moreover, the effect of IU-dsRNA on gene expression was specific for ISGs. 
Base pairs that differ between the pairs of dsRNAs are in bold. Biotinylated (Bio) dsRNAs are indicated.
a r t i c l e s
IU-dsRNA has a prolonged effect on ISGs
In the previous experiments, expression of ISGs was evaluated 12 h after co-transfection of HeLa cells with short dsRNAs and poly(IC). We next tested whether suppression of ISGs by IU-dsRNA persisted over a longer time. We co-transfected HeLa cells with poly(IC) and control or C-IU dsRNA. We harvested cells after 6-54 h and used RT-qPCR to analyze the expression of various ISGs. Each ISG tested was upregulated in cells transfected with poly(IC) and control dsRNA after 30-54 h (Fig. 2c) . By contrast, when C-IU dsRNA was co-transfected with poly(IC), the induction of ISGs was suppressed (Fig. 2c) .
The presence of C-IU dsRNA in cells therefore suppressed induction of ISGs over an extended time.
We also used immunoblots to analyze the expression of the ISGs after co-transfection of HeLa cells with poly(IC) and control or C-IU dsRNA ( Fig. 2d) . With poly(IC) and control dsRNA, the expression of all ISGs was increased 30-54 h after transfection (Fig. 2d , lanes 3, 5 and 7), relative to 6 h (Fig. 2d, lane 1) . By contrast, cells transfected with poly(IC) and C-IU dsRNA (I) did not show increased expression ( Fig. 2d, lanes 4, 6 and 8 ). These data confirmed that IU-dsRNA suppressed the induction of ISGs.
Multiple IU pairs are needed to suppress ISGs
We used several short duplexes (C-IU, IIUI, 142-IU) to show that IU-dsRNA suppressed the induction of ISGs by poly(IC). We next investigated how many IU pairs were required for suppression.
We transfected HeLa cells with poly(IC) and either a perfect Watson-Crick duplex (GP; Table 1 ) or an IU-dsRNA containing 2, 3, 4 or 6 IU pairs (UI, IUI, IIUI or 6I, respectively). In addition, we tested a duplex containing IC pairs (IC) to determine whether inosine was sufficient for suppression per se. We also tested a duplex containing four isosteric GU pairs (GGUG). Again, with the exception of the central 4-6 bp, the sequences of the dsRNAs tested were identical. We used RT-qPCR to analyze the expression of ACTB and various ISGs 12 h after transfection ( Fig. 2e) . In the presence of GP dsRNA and poly(IC), expression of all ISGs increased. The expression of ACTB was unchanged. By contrast, the induction of ISGs was significantly reduced in cells transfected with 6I IU-dsRNA and poly(IC) ( Fig. 2e , compare expression relative to that with GP). Moreover, as the number of IU pairs in the IU-dsRNAs decreased, Table 1 ).
(a) HeLa cells were transfected with control (C) or C-IU dsRNAs, with or without Fluc mRNA. Fold change in mRNA after 12 h was calculated relative to expression at 6 h in cells transfected with C dsRNA and normalized to GAPDH (n = 4). *, P = 0.001; **, P < 5 × 10 −4 . (b) HeLa cells were transfected with 0-500 ng Fluc mRNA. Fold change in mRNA was calculated relative to that seen without Fluc mRNA and normalized to GAPDH (n = 4). (c) HeLa cells were co-transfected with Fluc mRNA and either control dsRNAs (C, GP or 142) or IU-dsRNAs (C-IU, IIUI or 142-IU). Fold change in mRNA after 12 h was calculated relative to expression at 6 h in cells transfected with GP dsRNA and normalized to GAPDH (n = 4). *, P < 5 × 10 −3 ; **, P < 1 × 10 −3 . Bars, mean ± s.d.
Figure 2
IU-dsRNA suppressed induction of ISGs by poly(IC). We used RT-qPCR to quantify expression of ACTB, different ISGs and control genes, or immunoblotting to analyze expression of ISG products ( Supplementary Table 1 ).
(a) HeLa cells were transfected with 0-500 ng poly(IC). Fold change in mRNA after 12 h was calculated relative to that seen without poly(IC) and normalized to GAPDH (n = 4). (b) HeLa cells were co-transfected with poly(IC) and control (C) or C-IU dsRNAs. Fold change in mRNA after 12 h was calculated relative to that seen at 6 h in cells transfected with C dsRNA and normalized to GAPDH (n = 4). *, P < 1 × 10 −3 ; **, P < 5 × 10 −4 . (c) HeLa cells were cotransfected with poly(IC) and C or C-IU dsRNA. Fold change in mRNA after 30, 48 and 54 h was calculated relative to that seen at 6 h in cells transfected with C dsRNA and normalized to GAPDH. (d) HeLa cells were co-transfected with poly(IC) and C or C-IU (I) dsRNA, and expression of ISG products was analyzed by immunoblotting after 6, 30, 48 and 54 h. Actin was a loading control. (e) HeLa cells were cotransfected with poly(IC) and either control dsRNA (GP) or IU-dsRNAs with two, three, four or six IU pairs (UI, IUI, IIUI and 6I, respectively). dsRNAs with GU or IC pairs (GGUG or IC, respectively) were also tested. Fold change in mRNA after 12 h was calculated relative to that seen at 6 h in cells transfected with GP dsRNA and normalized to GAPDH (n = 4). *, P < 1 × 10 −3 ; **, P < 1 × 10 −4 . Bars, mean ± s.d. Interferon-stimulated genes 250 500 6I  IIUI  IUI  UI  GGUG  IC  GP  6I  IIUI  IUI  UI  GGUG  IC  GP  6I  IIUI  IUI  UI  GGUG  IC  GP  6I  IIUI  IUI  UI  GGUG  IC  GP  6I  IIUI  IUI  UI  GGUG  IC we found a corresponding decrease in suppression of ISGs. The GGUG duplex caused a small amount of repression ( Fig. 2e) . However, this was substantially less than that seen with the equivalent IU-dsRNA (IIUI). By contrast, IC dsRNA did not suppress the induction of ISGs by poly(IC) ( Fig. 2e) . This observation confirmed that IU pairs were essential for suppression. These data show that multiple IU pairs were required to efficiently suppress the induction of ISGs.
IU-dsRNAs undergo specific cleavage in various cell lysates 11 . Using various synthetic duplexes that correspond to potential cleavage products of IIUI IU-dsRNA 11 , we showed that relatively short IU-dsRNAs containing multiple inosine residues also suppressed the induction of ISGs ( Supplementary Fig. 2 ).
Inhibition of gene expression is specific for ISGs
We next used microarrays to look more globally at the effects of IU-dsRNA on gene expression. We transfected HeLa cells with poly(IC) and control or C-IU dsRNA and harvested the RNA after 12 h. We carried out three independent experiments for microarray analyses. Using the microarrays, we analyzed gene expression in the presence of control or C-IU dsRNA and calculated the fold change in mRNA with control dsRNA relative to that with C-IU dsRNA. The expression of 59 genes was ≥1.5-fold greater with control than with C-IU dsRNA after 12 h (Supplementary Table 2 ). This gene set included most of the ISGs analyzed in Figures 1 and 2 . Using gene ontology analyses (PANTHER) 25 , we found that the set of 59 genes was significantly enriched for genes involved in biological processes such as interferon-mediated immunity and immunity and defense ( Fig. 3 and Supplementary Table 3 ). This observation was consistent with the idea that IU-dsRNA suppressed the induction of genes involved in the interferon response. Several genes involved in apoptosis were also overrepresented. We analyzed pathways and molecular functions related to the 59 genes and found that they were also significantly enriched for terms that supported roles in immunity and defense ( Supplementary Table 3 ). These data confirm that IU-dsRNA specifically suppressed the induction of genes involved in immune responses.
To validate the microarray data, we analyzed the expression of approximately half of the 59 genes identified. We transfected HeLa cells with poly(IC) and control or C-IU dsRNA and harvested them after 2 or 12 h. We used RT-qPCR to analyze gene expression. We calculated the fold change in mRNA levels at 12 h relative to those at 2 h with control dsRNA and normalized them to GAPDH. In the presence of poly(IC) and control dsRNA, the expression of all genes tested was upregulated 1.4-to 400-fold ( Fig. 4a) . By contrast, C-IU dsRNA suppressed the induction of gene expression ( Fig. 4a ). When we analyzed seven genes that were unchanged on the array with poly(IC) and control or C-IU dsRNA, we found no induction by poly(IC) or suppression by C-IU dsRNA, as expected (Fig. 4b) . These results validate the data obtained using microarrays, where induction of ISGs by poly(IC) was specifically repressed by C-IU dsRNA.
IU-dsRNA inhibited poly(IC)-induced apoptosis
Transfection of HeLa cells with poly(IC) triggered an interferon response characterized by induction of ISGs. Moreover, transfection of cells with poly(IC) also induces apoptosis 26, 27 . Throughout the experiments described above, we consistently observed more cell death after transfection with poly(IC) and control dsRNA than with poly(IC) and C-IU dsRNA. We therefore investigated whether cell death was due to apoptosis, and we tested the effect of control or C-IU dsRNA.
To quantify the amount of cell death after co-transfection with poly(IC) and control or C-IU dsRNA, we counted the number of dead cells in the supernatant after 12-24 h (Fig. 5a) . This confirmed that the amount of cell death increased over time for cells transfected with control but not C-IU dsRNA. These data suggested that C-IU dsRNA protected against cell death.
To investigate whether apoptosis was responsible for cell death, we transfected HeLa cells with poly(IC) and control or C-IU dsRNA or treated them with camptothecin (CPT), with or without control or C-IU dsRNA. Treatment of cells with CPT induces apoptosis 28 . We prepared cell lysates from adherent cells after 12 h, and we used immunoblotting to analyze cleavage of poly(ADP-ribose) polymerase (PARP), a hallmark of apoptosis 29 . Under all conditions tested, we detected full-length PARP (PARP) (Fig. 5b, lanes 1-5) . When we treated cells with CPT, with or without control or C-IU dsRNA, we saw a band corresponding to cleaved PARP (cPARP) (Fig. 5b,  lanes 3-5) . Similarly, when we transfected cells with poly(IC) and control dsRNA, we detected cPARP (lane 1). By contrast, we did not detect cPARP in cells treated with poly(IC) and C-IU dsRNA (lane 2). These data confirm that cell death in response to poly(IC) was due to apoptosis. Moreover, they suggest that C-IU inhibited apoptosis.
We used fluorescence-activated cell sorting (FACS) to confirm that cell death in response to poly(IC) resulted from apoptosis. We transfected HeLa cells with poly(IC) and control or C-IU dsRNA or treated them with CPT as a control for apoptosis. We also carried out mock transfections. After 12-24 h, we labeled adherent cells with Annexin V and propidium iodide, which stain apoptotic or dead (apoptotic/ necrotic) cells, respectively. We then used FACS to determine what proportion of cell death resulted from apoptosis. Representative FACS data from the 24 h time point are shown (Fig. 5c) , and data obtained from multiple experiments are summarized graphically (Fig. 5d , n = 4). As expected, CPT treatment increased apoptosis (Fig. 5c,d) . Similarly, HeLa cells transfected with poly(IC) and control dsRNA underwent substantially more apoptosis than mock-transfected cells (+LF-2000). By contrast, we found no substantial increase in apoptosis in cells transfected with poly(IC) and C-IU dsRNA relative Figure 3 Genes involved in immunity and defense were enriched. The 59 genes enriched ≥1.5-fold in cells transfected with poly(IC) and control (C) dsRNA relative to C-IU dsRNA on the microarray were subject to gene ontology analyses (PANTHER) and classified according to biological process (P ≤ 0.05). The numbers of genes in the set of 59 that belong to each class are given; the numbers expected with reference to the control database (NCBI: H. sapiens genes (25, 431) ) are shown in parentheses.
a r t i c l e s to mock-transfected cells. These data support the observation that C-IU dsRNA inhibited poly(IC)-induced apoptosis.
IU-dsRNA inhibits activation of IRF3
When poly(IC) is used to transfect mammalian cells, it is recognized by the cytosolic sensors MDA-5 and RIG-I (Supplementary Fig. 3 ) 19 . This leads to activation of the transcription factor IRF3, which triggers production of type I interferons and ultimately induces a transcriptional cascade 18 . The activation of IRF3 requires phosphorylation of multiple residues, followed by homodimerization and nuclear translocation 30, 31 . IRF3 is also required for virus-or dsRNAinduced apoptosis [32] [33] [34] [35] . We therefore investigated whether IU-dsRNA inhibited the activation of IRF3, which would provide a plausible explanation for how IU-dsRNA suppressed both the interferon and apoptotic pathways. We transfected HeLa cells with poly(IC) and control or C-IU dsRNA and harvested them after 2-36 h. We used RT-qPCR was used to verify that ISG expression was upregulated by poly(IC) and control dsRNA at each time point but suppressed by C-IU dsRNA (Fig. 6a) .
We used immunoblotting to test whether IRF3 was activated by phosphorylation in cells transfected with poly(IC) and control or C-IU dsRNA. Using a specific IRF3-phospho antibody (IRF3 S396-P), we showed that phosphorylation of IRF3 occurred in cells transfected with poly(IC) and control dsRNA after 12-36 h (Fig. 6b, lanes 3, 5, 7 and 9 ). By contrast, C-IU dsRNA suppressed IRF3 phosphorylation (Fig. 6b, lanes 4, 6, 8  and 10 ). In the absence of poly(IC), IRF3 was not phosphorylated in cells transfected with either control or C-IU dsRNA (Supplementary Fig. 4a ). We obtained equivalent results using another unrelated pair of duplexes (GP and 6I; Supplementary  Fig. 4b) . These data showed that IU-dsRNA inhibited the activation of IRF3. When the immunoblot was additionally probed with anti-IRF3, which detects total IRF3, we found that cells transfected with control but not C-IU dsRNA showed reduced levels of IRF3 at 24 and 36 h (Fig. 6b, compare  lanes 7 and 8 or 9 and 10 ). This is consistent with previous studies showing proteolysis of IRF3 following activation 30 . Finally, we probed the immunoblot with anti-PARP, which only detected cPARP in cells transfected with poly(IC) and control but not C-IU dsRNA (Fig. 6b,  compare lanes 3, 5, 7 and 9 with lanes 4, 6, 8 and 10 ). Thus C-IU dsRNA inhibited IRF3 activation and apoptosis. This observation was also made using other cell lines (Supplementary Fig. 4c ) and in the previous experiment, where we found both IRF3 phosphorylation and cPARP in cells transfected with poly(IC) and control but not C-IU dsRNA (Fig. 5b, lanes 1 and 2) . Together, these data confirmed that C-IU dsRNA prevented IRF3 activation.
Next, we analyzed the dimerization of IRF3 using native gels and immunoblotting. When we transfected HeLa cells with poly(IC) and control dsRNA, we found IRF3 dimers after 12-36 h (Fig. 6c, lanes  3, 5, 7 and 9 ). By contrast, there was substantially less dimerization of IRF3 in cells transfected with poly(IC) and C-IU dsRNA (lanes 4, 6, 8 and 10). These data were consistent with the idea that IU-dsRNA inhibits the activation, and hence the dimerization, of IRF3.
IRF3 translocates to the nucleus after phosphorylation and dimerization 30, 31 . To investigate the subcellular localization of active IRF3, we prepared nuclear and cytoplasmic fractions 24 h after IRF7   STAT1  CCL20  ISG20  ZNFX1  MX1  IL6  IL8  KLF6  PPP1R15A  NFKBIA   ACTB  EIF4G2  RPS24 MRFAP1L1 TBC1D22B PPP2R2D  G3BP2   Herc5  IL29  IFITM1  IRF9  MDA-5  CFB  UBE2L6 PRIC285 ZC3HAV1 a r t i c l e s transfection of cells with poly(IC) and control or C-IU dsRNA, and analyzed them using immunoblots (Fig. 6d) . Lamin A/C and tubulin were nuclear and cytoplasmic markers, respectively. In cells transfected with poly(IC) and control or C-IU dsRNA, the localization of total IRF3 (IRF3) was predominantly nuclear, consistent with the observation that inactive IRF3 shuttles into and out of the nucleus 18 . By contrast, phosphorylated IRF3 (IRF3 S396-P) was strongly enriched in the nuclear fraction of cells transfected with poly(IC) and control dsRNA (Fig. 6d) whereas we detected very little phosphorylated IRF3 in cells transfected with C-IU dsRNA. These data confirmed that activation of IRF3 by phosphorylation and nuclear translocation occurred in cells transfected with poly(IC) and control but not C-IU dsRNA. By analyzing IRF3 phosphorylation, dimerization and nuclear localization we showed that IU-dsRNA inhibits the activation of IRF3. In so doing, we have provided an explanation for how IU-dsRNA inhibits both the interferon and apoptotic pathways.
IU-dsRNA interacts specifically with MDA-5 and RIG-I
We have shown that IU-dsRNA inhibited activation of IRF3. We next asked whether IU-dsRNA inhibits an earlier step in the pathway that precedes activation of IRF3 (Supplementary Fig. 3) . We focused on whether IU-dsRNA interacts with MDA-5 or RIG-I, the cytosolic sensors for poly(IC).
We first tested whether IU-dsRNA interacts with MDA-5. We overexpressed MDA-5 in HeLa cells for 24 h and then transfected them with specific (biotinylated C-IU (Bio-C-IU); Table 1 ) or nonspecific (control or Bio-C) dsRNAs. After 12 h, we prepared lysates and captured RNA-protein complexes using streptavidin beads. Immunoblotting showed that MDA-5 specifically bound Bio-C-IU (bI) but not Bio-C (bC) or control dsRNAs (Fig. 7a, compare lane 4  with lanes 5 and 6) . Therefore, IU-dsRNA specifically interacts with MDA-5.
We next investigated whether C-IU dsRNA interfered with the activation of IRF3 by MDA-5. We overexpressed MDA-5 in HeLa cells for 24 h, transfected them with control or C-IU dsRNA, and prepared lysates after 12 h. We also carried out control transfections (mock, poly(IC)). Analysis with RT-qPCR confirmed that overexpression of MDA-5 induced ISGs 36 (data not shown). Moreover, immunoblots showed that RIG-I was substantially upregulated by overexpressed MDA-5 (Fig. 7b) . However, as it was likely to be inactive in the absence of poly(IC) 36, 37 , RIG-I was unlikely to contribute to the activation of IRF3. We analyzed the activation of IRF3 using immunoblots. When MDA-5 was overexpressed, cells transfected with control dsRNA contained considerably more phosphorylated IRF3 than cells transfected with C-IU dsRNA (Fig. 7b, compare lanes 3 and  4, and Fig. 7c ). This was not due to differential expression of MDA-5 (Fig. 7b, lanes 3 and 4, and Fig. 7c ). Furthermore, RT-qPCR analysis confirmed that the induction of ISGs by MDA-5 was substantially higher in cells transfected with control dsRNA than C-IU dsRNA (data not shown). We also analyzed apoptosis using anti-PARP. In keeping with the different levels of phosphorylated IRF3, cells transfected with control dsRNA contained more cPARP than cells transfected with C-IU dsRNA (Fig. 7b, compare lanes 3 and 4, and  Fig. 7c ). Together, these data show that C-IU dsRNA inhibited pathways initiated by MDA-5. This inhibition might result from specific binding of IU-dsRNA to MDA-5.
We next tested whether C-IU interacted with a truncated version of MDA-5 that lacks the C-terminal region (MDA-5 ΔC) that has been implicated in ligand binding 38 . We expressed MDA-5 or MDA-5 ΔC in HeLa cells (Fig. 7d , MDA-5 or Flag antibodies, respectively, lane 1) and incubated lysates with streptavidin beads coupled to specific (Bio-C-IU) or nonspecific (control or Bio-C) dsRNAs. Analysis of the dsRNA-protein complexes showed that MDA-5 specifically bound Bio-C-IU dsRNA, as expected (Fig. 7d, lane 2 , MDA-5). By contrast, MDA-5 ΔC did not bind Bio-C-IU dsRNA (Fig. 7d, lane 2, Flag) . These data suggest that C-IU dsRNA binds MDA-5 through the C-terminal half of the protein, so it could interfere with ligand binding and subsequent activation.
We also probed the immunoblot for RIG-I, which was induced by expression of either MDA-5 or MDA-5 ΔC. RIG-I also preferentially bound Bio-C-IU compared to Bio-C or control dsRNA (Fig. 7d) . Moreover, with reference to the load, RIG-I appeared to bind more efficiently than MDA-5 to C-IU dsRNA (Fig. 7d, compare lanes 1  and 2) . When RIG-I was induced by transfection of HeLa cells with poly(IC), RIG-I specifically bound C-IU dsRNA (Fig. 7e) . These data show that C-IU dsRNA specifically bound RIG-I as well as MDA-5.
Finally, we investigated whether binding of C-IU dsRNA to RIG-I could interfere with ligand binding. We prepared lysates from HeLa cells overexpressing MDA-5 (and therefore containing increased levels of RIG-I) and incubated them with Bio-C-IU-coupled streptavidin beads in the presence of increasing concentrations of poly(IC). In the absence of poly(IC), RIG-I bound C-IU dsRNA (Fig. 7f,  lane 2) . As the concentration of poly(IC) increased, the binding of RIG-I to C-IU dsRNA decreased (Fig. 7f, lanes 3-5) . By contrast, a nonspecific RNA did not reduce binding (data not shown). These Supplementary Table 1 ) after 12-36 h (n = 4). Fold change in mRNA was calculated relative to that seen at 2 h in cells transfected with C dsRNA and normalized to GAPDH. Bars, mean ± s.d.
(b) We used immunoblots to detect IRF3 activation (IRF3 S396-P) and total IRF3 (IRF3). Detection of cPARP indicated apoptosis. Actin was a loading control. (c) We analyzed dimerization of IRF3 using native gels and immunoblotting (IRF3). (d) We transfected HeLa cells with poly(IC) and C or C-IU dsRNA and prepared nuclear (N) and cytoplasmic (Cyt) lysates. Lamin A/C and tubulin were markers for N and Cyt lysates, respectively. We used immunoblots to detect total IRF3 (IRF3) and IRF3 activation (IRF3 S396-P).
a r t i c l e s data suggest that binding of C-IU dsRNA and poly(IC) to RIG-I are mutually exclusive and lead us to speculate that C-IU dsRNA might inhibit RIG-I by interfering with ligand binding. We have shown that C-IU dsRNA inhibits MDA-5 and specifically binds both MDA-5 and RIG-I. We therefore propose that IU-dsRNA exerts its inhibitory effects on the interferon and apoptotic pathways by specifically interacting with RIG-I or MDA5, which in turn prevents the activation of IRF3 and subsequent signaling events.
DISCUSSION
Our results shed light on the role of IU-dsRNA in mammalian cells. We have shown that IU-dsRNA selectively suppresses the induction of ISGs in response to long dsRNA. IU-dsRNA also downregulates the expression of both endogenous and reporter genes in trans 13 . Although the identity of the endogenous genes was previously unknown, we now speculate that they were ISGs. It will be interesting to discover how the downregulation of reporter genes relates to our current findings.
We have also shown that IU-dsRNA inhibits poly(IC)-induced apoptosis (Figs. 5-7) . One mechanism by which poly(IC) induces apoptosis is through upregulation of the proapoptotic TNF-related apoptosis-inducing ligand (TRAIL), a direct transcriptional target of IRF3 (ref. 39) . We speculate that TRAIL might be important for the apoptosis we observed, as its expression was upregulated by poly(IC) and control dsRNA but repressed by C-IU dsRNA (Supplementary Fig. 5 ). Furthermore, X-linked inhibitor of apoptosis-associated factor 1 (XAF1), an interferondependent factor that sensitizes cells to the proapoptotic effects of TRAIL 40 , was activated by poly(IC) and control but not C-IU dsRNA (Supplementary Fig. 5 ). However, regardless of the mechanism by which poly(IC)-induced apoptosis occurs, we have shown that apoptosis was suppressed by IU-dsRNA.
We have shown that IU-dsRNA inhibits the phosphorylation of IRF3 (Fig. 6) , which is essential for the induction of ISGs and apoptosis [31] [32] [33] [34] [35] . Moreover, IU-dsRNA was unable to inhibit the induction of ISGs by a phosphomimetic IRF3 mutant (IRF3 5D 30 ; Supplementary Fig. 6 , and see Supplementary Methods). Consistent with our observations, a recent study showed that IRF3 is activated in ADAR1-deficient cells 41 . We further investigated the effect of IU-dsRNA at earlier steps in the pathway leading to IRF3 activation, and thus speculate that IU-dsRNA might interfere with the initial recognition of poly(IC) by either RIG-I or MDA-5 ( Fig. 7) .
Our findings are in keeping with previous studies that suggest that ADAR1 is essential for survival. ADAR1-deficient HeLa cells show increased apoptosis after viral infection 41 . Early embryonic death in Adar1 −/− mice results from widespread apoptosis and defective hematopoiesis 16 . Mouse embryonic fibroblasts derived from Adar −/− embryos are prone to apoptosis during serum starvation 16 . ADAR1deficient hematopoietic progenitor cells show increased apoptosis 42 . In addition, loss of ADAR1 in hematopoietic stem cells leads to global upregulation of ISGs and rapid apoptosis 17 . These observations led to the idea that ADAR1 promotes cell survival by suppressing the potentially deleterious effects of interferon activation. Our findings now provide an explanation for how ADAR1 regulates interferon signaling.
Various targets for hyperediting by ADARs have been described in mammalian cells. Analysis of RNA from human brain showed editing in noncoding regions 5 . Moreover, bioinformatic analyses predicted that >5% of human mRNAs contain editing sites in noncoding sequences, such as Alus 4, 6, 7 . miRNA precursors might also be edited 43 . dsRNA arising from viral infection is another likely editing target. We speculate that editing of any of these putative targets by ADAR1 will give rise to IU-dsRNA that has the potential to suppress the immune response.
Restricted expression of ADAR1 p150 might regulate the production of IU-dsRNA. p150 is expressed in response to interferon 14 and serum starvation 16 . Induction of p150 by interferon might represent a negative feedback mechanism whereby its upregulation during stress acts to dampen down the interferon response, thus enabling cell survival. Expression of p150 is higher than that of the constitutive (p110) isoform in hematopoietic stem cells, where ADAR1 is essential for survival. By contrast, p110 is expressed almost exclusively in embryonic stem cells, where ADAR1 is dispensable 17 . Increased expression of p150 might be critical in maintaining the delicate balance between cell survival and death.
We have provided evidence that IU-dsRNA per se suppresses ISG induction and apoptosis in response to long dsRNA. This represents a novel function for IU-dsRNA, and hence for editing by ADARs, in mammalian cells.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
